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Abstract
Background: Expression profiling provides new insights into regulatory and metabolic processes and in particular
into pathogenic mechanisms associated with diseases. Besides genes, non-coding transcripts as microRNAs
(miRNAs) gained increasing relevance in the last decade. To understand the regulatory processes of miRNAs on
genes, integrative computer-aided approaches are essential, especially in the light of complex human diseases as
cancer.
Results: Here, we present miRTrail, an integrative tool that allows for performing comprehensive analyses of
interactions of genes and miRNAs based on expression profiles. The integrated analysis of mRNA and miRNA data
should generate more robust and reliable results on deregulated pathogenic processes and may also offer novel
insights into the regulatory interactions between miRNAs and genes. Our web-server excels in carrying out gene
sets analysis, analysis of miRNA sets as well as the combination of both in a systems biology approach. To this end,
miRTrail integrates information on 20.000 genes, almost 1.000 miRNAs, and roughly 280.000 putative interactions,
for Homo sapiens and accordingly for Mus musculus and Danio rerio. The well-established, classical Chi-squared
test is one of the central techniques of our tool for the joint consideration of miRNAs and their targets. For
interactively visualizing obtained results, it relies on the network analyzers and viewers BiNA or Cytoscape-web, also
enabling direct access to relevant literature. We demonstrated the potential of miRTrail by applying our tool to
mRNA and miRNA data of malignant melanoma. MiRTrail identified several deregulated miRNAs that target
deregulated mRNAs including miRNAs hsa-miR-23b and hsa-miR-223, which target the highest numbers of
deregulated mRNAs and regulate the pathway “basal cell carcinoma”. In addition, both miRNAs target genes like
PTCH1 and RASA1 that are involved in many oncogenic processes.
Conclusions: The application on melanoma samples demonstrates that the miRTrail platform may open avenues
for investigating the regulatory interactions between genes and miRNAs for a wide range of human diseases.
Moreover, miRTrail cannot only be applied to microarray based expression profiles, but also to NGS-based
transcriptomic data. The program is freely available as web-server at mirtrail.bioinf.uni-sb.de.
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Gene expression profiles have gained increasing rele-
vance over the last three decades and have become
essential in modern biomedical sciences. About two dec-
ades ago, a further class of RNAs has been discovered:
these non-coding oligonucleotides are indeed tran-
scribed from the human genome, but no proteins are
assembled according to their blueprints. MicroRNAs are
a subgroup of these non-coding RNAs, currently attract-
ing more and more attention. They have first been
reported in a work by Ruvkun [1] and their first appear-
ance in experiments has been associated with Lee et al
[2].
MicroRNAs usually consist of 17 to 23 nucleotides
and are detectable in the majority of human tissues and
almost all bodily fluids [3-5]. It is known today that
microRNAs influence the expression of target genes by
binding to the corresponding mRNA, leading to its inac-
tivation. Over 50% of all human coding genes seem to
be targets of these short non-coding RNAs. MicroRNAs
hereby help to control and fine-tune physiological cellu-
lar processes like differentiation, proliferation, or apop-
tosis. Nowadays, it also became apparent that
microRNAs have a strong impact on pathological pro-
cesses as well: Various microRNAs show altered expres-
sion patterns in human disorders including malignant
[6-10], neurological [11], cardiovascular [12,13], or rheu-
matic diseases [14,15]. In order to get new insights into
the molecular mechanisms leading to a specific disease,
increasing attention is paid to the interaction of micro-
RNAs and mRNAs of target genes.
The technologies that are most commonly applied to
measure miRNA expression profiles are closely related
to the methods for measuring gene expression profiles,
namely quantitative real-time polymerase chain reaction
(qRT-PCR) [16,17], oligonucleotide microarrays [18,19],
and high-throughput sequencing [20,21]. These three
technologies allow measuring the expression of sets of
miRNA very efficiently. While qRT-PCR is mostly
applied to rather small subsets of miRNAs, microarrays
enable to profile the whole human miRNome and high-
throughput sequencing is additionally applied to detect
novel mature forms of miRNAs. Remarkably, with the
still growing number of miRNAs, and the likewise grow-
ing number of biological experiments carried out with
the above-mentioned high-throughput methods, and the
manifold of possible interactions between miRNAs and
mRNAs, computer aided analyses are essential to grasp
the information hidden in the large data sets. Therefore,
much ongoing work focuses on the combined analysis
of miRNAs and their targets. Two classes of bioinfor-
matics approaches related to this topic are 1) tools that
a i ma td i s c o v e r i n gt h et a r g e t so fm i R N A sa n d2 )t o o l s
that aim at an integrative analysis of miRNA and mRNA
sets. Algorithms belonging to the first class usually rely
on sequence-complementarity and often also include
thermodynamical aspects [22], machine learning [23-25],
or experimental validation steps [26]. An overview of
respective programs, including a comparison, can be
found in [27]. Additionally, approaches primarily based
on experiments are becoming prominent in recent years
[28,29]. Naturally, these approaches are more likely to
reveal significant miRNA - mRNA interaction pairs than
computational approaches. However, they usually
require not unimportant amounts of time and resources
and, e.g. by design, might also miss relevant interactions.
While not strictly being a tool for the discovery of tar-
gets or for an integrated analysis of miRNA and mRNA
sets, TAM [30] offers enrichment analyses on miRNA
sets, thus potentially paving the way to link common
functions with related miRNAs. Tools for the second
purpose, an integrative analysis of genes and their
miRNA regulators, include MMIA [31], DIANA-mirEx-
Tra [32], or miRGator [33]. MMIA, allows to combine
expression profiles of miRNA and mRNA experiments
and then performs a pathway analysis on the intersec-
tion of the predicted target mRNAs and the according
inversely correlated mRNAs. Additional analyses include
Transcription Factor Binding Sites enrichment and dis-
eases that are found to be associated with the inversely
deregulated miRNAs. DIANA-mirExTra web-server
integrates the potentially novel prediction of miRNAs
having one or more of the submitted genes as their tar-
gets. This, likewise, allows shedding light on the func-
tion of the miRNAs. In detail, the algorithm investigates
the 3’ UTR sequences of deregulated genes and searches
for over-represented six nucleotide long motifs, thus,
enabling the identification of matching miRNAs. Finally,
miRGator uses public expression data to analyze expres-
sion correlation between miRNA and target mRNA/pro-
teins. The miRNA - target interactions are based on
miRanda [22], PicTar [34], and TargetScanS [35] and
the function of miRNAs is inferred from the related tar-
get mRNAs. To this end, a statistical enrichment analy-
sis is performed for the established GO-terms, pathways,
and also disease associations. Moreover, it integrates a
first approach towards a manual inspection of the
underlying network, offering vertex- or edge-filtering
but, to-date, no ways to further cope with this informa-
tion. Here, we present miRTrail (freely available to non-
commercial users at mirtrail.bioinf.uni-sb.de), a knowl-
edge-based tool for integrative network analysis that
allows for studying the interactions between microRNAs
and their target genes, and especially in the case of dis-
eases, the implications of expression changes on patho-
genic processes. Our tool excels by its broad
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Page 2 of 13functionality, as (1) it can be applied to a single disease
or a group of diseases, (2) it covers a wide variety of
biochemical categories, and it can be used to evaluate
(3) qRT-PCR, microarray, as well as NGS-based tran-
scriptome data. In its current stage, the organisms of
Homo sapiens, Mus musculus, and Danio rerio are sup-
ported and further extension is continuing. While many
solutions exist that provide either analyses of miRNAs,
or mRNAs, or a combination of both, miRTrail allows
for the simultaneous, combined statistical analysis of all
of these three. A schematic description of its workflow
is presented in Figure 1, depicting the integration of the
provided data about miRNA and mRNA deregulation
and the offered statistical analyses intended to facilitate
the work with such complex information, especially
when used in combination. As such, our tool is able to
not only give initial but also thorough insights, even for
a very detailed inspection of the given input based on
the network analysis.
One of the original goals of our research was to
improve the understanding on the molecular level of
melanoma. Thus, as a first application, we investigated
miRNA and mRNA expression profiles of this cancer
entity, integrating information from 1) the gene expres-
sion omnibus GEO [36], 2) the PhenomiR 2.0 human
miRNA and diseases database [37], 3) target prediction
algorithms [38], and 4) biochemical pathway information
of different resources integrated via the BNDB and
GeneTrail [39]. By applying miRTrail to these data, we
found highly significant coherences between dysregu-
lated miRNAs and matching dysregulated targets of
these miRNAs. An additional network analysis high-
lighted the potential implications of eight miRNAs via
their target mRNAs on pathogenic processes in
melanomas.
Implementation
In this section, we start by describing the general idea
behind miRTrail, followed by the data, techniques and
tools that are used to provide the rich functionality, as
well as information on the exemplary input data.
Here, the input is originating from publicly available
services like NCBI GEO and PhenomiR. Our tool is
n o tr e s t r i c t e dt ot h e s es e r v i c e s ,a st h e ya r ei n t e n d e d
for demonstration purposes. Especially, all of miR-
Trail’s functionality is available for the organisms of
Homo sapiens, Mus musculus, and Danio rerio, and
can easily be extended to support other organisms in
the future.
Methodoloy - Multipartite graph
O u rw e b s e r v i c em i R T r a i la l l o w sf o rt h ej o i n t / i n t e g r a t e d
analysis of miRNA and mRNA entities, in respect to
given diseases - since the latter protein-coding RNAs
are targets of the former non-coding RNAs. We decided
to realize the integration of data by constructing a graph
Figure 1 Workflow. Workflow of miRTrail. User submits two RNA sets (one is the set of deregulated miRNAs, the other is the set of deregulated
mRNAs, both for the same disease). Orange color represents information flow of miRNA-related information: For each provided miRNA, the
target mRNAs are determined (based on microCosm predictions or custom, uploaded interactions). This information then is used by miRTrail,
indicated by the red arrow. In general, red color represents flow of mRNA-related information: The uploaded mRNA set as well as the miRNA
targets are used in GeneTrail to perform ORAs as described in the “Methods"-section. Blue color represents information flow of results-related
information, e.g. for the overlap of pathway sets. Finally in the results, the network analysis allows for targeted inspection of the provided
information, based e.g. on miRNA families-related subnetworks. The modular design of miRTrail becomes visible here, also allowing for
convenient extension of future analyses and usage for a diversity of different organisms.
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graph G:
G = (V,E)
with:
￿ V = VmiR ∪ VmR ∪ Vdi
￿ VX ∩ VY = ∅ for X ≠ Y and X, Y Î {miR, mR, di}
￿ E = EmR-di ∪ EmiR-di ∪ EmiR-mR
￿ EX − Y ={ ( u, v)| u Î VX ,vÎ VY ,X≠ Y}f o rX, Y
Î {miR, mR, di}
where the vertex-set V is the union of disjoint vertex-
subsets, the edge-set E is the union of disjoint edge-sub-
sets, and an edge only connects vertices of different ver-
tex-subsets.
For each user and the according uploads, individual
networks are created. An efficient and open-source
interface for the creation of graphs is offered by the C+
+ Boost Graph Library and the associated adjacen-
cy_list-construct.
MicroRNA - Target mRNA Interactions
The actually known 20,000 genes and 1,000 miRNAs
allow for 20 million possible interaction pairs, where a
m i R N Am a yr e g u l a t eag e n e .T of i n dt h em o s tr e l i a b l e
candidates, prediction algorithms have been developed.
One of the most prominent algorithms for miRNA - tar-
get mRNA interactions is the miRanda algorithm and
the respective web-resource microCosm [38]. The miR-
anda algorithm is sequence-complementarity based and
includes a thermodynamic analysis of the miRNA - tar-
get mRNA complex. The results are then post-processed
by a filtering on conservation of the target site. Micro-
Cosm offers miRNA - target mRNA interactions in
combination with a p-value threshold. In the beginning,
we decided to perform analyses for three thresholds
(0.01, 0.001, 0.0001), and extracted all interactions hav-
ing a value smaller than the respective alpha level, yield-
ing 279,225, 85,050, and 26,984 interactions,
respectively. Because of the heterogenity of the expres-
sion data, we finally chose to use a threshold of 0.01, in
turn leading to approximately 400 target mRNAs per
miRNA in human. The appropriate predictions for the
other supported organisms are automatically selected by
miRTrail according to the organism in the identifiers of
the uploaded miRNA deregulation information.
Alternatively, custom pairwise miRNA - target mRNA
interactions can be uploaded in a tab-delimited format,
thus allowing e.g. for the use of experimentally validated
interactions. Details on the exact format for this input
can be found on the homepage of miRTrail, especially
regarding gene and miRNA identifiers.
Analysis of independance
Based on the pairwise miRNA - target mRNA interac-
tions (for a custom prediction-threshold (default of 0.01)
or from a custom list provided as upload), the miRNA
and (target) mRNA of each pair is compared to the
input in order to see if it is up-, down- or not deregu-
lated. This information is tabulated in a contingency
table to provide an overview to the user. An according
p-value is calculated, based on a Chisq-distribution with
4 (6 - 2) degrees of freedom. Given that the uploaded
information about dysregulated genes/mRNAs only con-
tains entries with the same direction of deregulation, the
computation of an according p-value is not allowed by
miRTrail and no p-value will be displayed, but instead a
note for the user. However, the table will nevertheless
be displayed as an overview.
To help the researcher get an impression about the
influence of the used miRNA - target mRNA interac-
tions in this step, especially when using data from pre-
diction algorithms, we of f e ra no p t i o nt or a n d o m i z e
upon the provided data of miRNA and mRNA deregula-
tion. The deregulation pattern (genes/miRs being up- or
downregulated) is kept as-is while the identifiers are
sampled at random. This functionality is available via
the “Randomize"-button.
MicroRNAs from PhenomiR
For integrating dysregulated miRNAs, we used Pheno-
miR 2.0 (last update: 2011-02-15). This service offers
manually curated data about differential regulation for a
variety of diseases.
Specifically, we used the data for entry/ID: 639, con-
cluding the results of a published melanoma study
based on microRNA low density arrays, including 666
microRNAs. Selection of the statistically significantly
dysregulated miRNAs in the miRNA extracts of adult
melanoma patients and benign nevi controls was done
with univariate Two-sample T-test and a significance
level of 0.05. The size of the patient samples is 10 and 4
for the control, respectively. An overview of the num-
bers of up- and downregulated miRNAs can be found in
Table 1.
MessengerRNAs from NCBI’s GEO
The NCBI Gene Expression Omnibus (GEO) is a public
repository providing data from microarray experiments,
Table 1 Summary of deregulated genes and miRNAs
# up-reg # down-reg sum of up and down
genes 2550 2218 4768
miRNAs 16 17 33
Deregulated genes (from NCBI GEO) (a = 0.05) and deregulated miRNAs
(Phenomir 2.0).
Laczny et al. BMC Bioinformatics 2012, 13:36
http://www.biomedcentral.com/1471-2105/13/36
Page 4 of 13next-generation sequencing, and other high-throughput
functional genomic data. The microarray experiments,
in particular, must comply with MIAME guidelines in
order to be accepted by NCBI’s GEO.
We extracted the microarray expression profiles from
data set GDS1375 (series published: 2005-08-25), includ-
ing 63 arrays for 45 melanoma and 18 benign nevi sam-
ples. Due to possible variations between the
experiments, we carried out a quantile-normalization of
the expression values for all genes present on the
respective data set. Selection of differentially expressed
genes was performed on the normalized data using the
univariate Two-sample T-test and a significance level of
0.05. An overview of the numbers of up- and downregu-
lated genes can be found in Table 1.
GeneTrail
The gene set analysis tool GeneTrail has been developed
to help in the analysis of readily available or newly cre-
ated high-throughput data. It allows for a comprehen-
sive and efficient statistical evaluation of large genomic
or proteomic datasets and covers a plethora of biological
categories and pathways,e . g .K E G G ,T R A N S P A T H ,
TRANSFAC, and GO. Analyses can be either performed
via an ‘Over-Representation Analysis’ (ORA) comparing
a reference set of genes to a test set or a ‘Gene Set
Enrichment Analysis’ (GSEA) based on a sorted list of
genes. While the calculation of ORA p-values relies on
Hypergeometric distribution, many existing tools offer
the calculation of GSEA p-values based on permutation
tests, usually limited to a fixed number of permutations
for performance reasons. GeneTrail integrates an exact
calculation [40] corresponding to a commonly used
non-parametric unweighted permutation test. This cal-
culation is based on dynamic programming and thus
allows, especially for large sets, a higher accuracy than
by using a fixed number of permutations.
Recently, GeneTrail has been extended to directly
allow the analysis of expression data originating from
the NCBI GEO, resulting in GeneTrail Express [41].
This integration greatly facilitates the selection of differ-
entially regulated genes and allows for a fast evaluation
of the expression profiles in respect to biological cate-
gories and pathways.
Visualization: BiNA and Cytoscape-web
While computational approaches are very important in
contemporary research, manual inspection is often
desireable to support the automatic analyses or to iden-
tify new aspects. To this end, we decided to include the
visualization of the resulting interaction network of
miRNAs and their (putative) targets. Due to the large
amount of integrated data, efficient means for focusing
are crucial. Therefore, we provide respective
subnetworks, depending either on the choice of indivi-
dual miRNAs or on members of miRNA-families con-
tained in the input. Furthermore, only deregulated
miRNAs are respected that are connected to deregulated
target mRNAs, either by the prediction algorithm or the
provided custom interactions, as we envision these enti-
ties and relations as the most relevant. For the actual
visualisation, two selections are available for the user:
BiNA and Cytoscape-web.
BiNA is a visualization and analysis tool for various
biological networks. We developed a plug-in for the Java
Webstart version of BiNA, which takes the miRTrail
results and uses the visualization capabilities of BiNA
for presenting the network. The user can choose
between different graph layouts (organic, hierarchic, and
orthogonal) and can modify the visualization in many
ways. By default, the target-mRNA nodes are sized
according to their degree for easier retrieval of high-
degree nodes. It is also possible to save the network in
different file formats for reusing the data in other tools
or BiNA again. For larger graphs, this visualization-
option is probably beneficial.
Cytoscape-web is modeled after the Cytoscape Java
network visualization and analysis software [42]. Its
JavaScript API allows for an integration into HTML-
pages and convenient display of networks. We offer the
user a choice of three different graph layouts (Circular,
Radial, Tree) and the possibility to select the first neigh-
bors of a selected node. Zoom and pan functionality is
available and target-nodes are also sized according to
their degree. As the graph is directly displayed in the
browser-window, this visualization is especially suitable
for a quick inspection of the network. Finally, we imple-
mented context-menu items that greatly facilitate the
search for related publications by performing NCBI
PubMed queries ("inclusive” or “exclusive”) for a custom
selection of miRNA and mRNA nodes, given a disease
was specified in the input.
Results and Discussion
In the following, we will describe the range of different
functions offered by miRTrail. Subsequently, an analysis
of cutaneous malignant melanoma versus benign nevi is
performed to illustrate the potential of our tool.
Functionality of miRTrail
The miRTrail webserver recieves two dysregulation sets
in separate text-files as input, one is the set of dysregu-
lated miRNAs and the other is the set of dysregulated
genes. For each uploaded identifier (for miRNAs, the
standard annotation of miRBase is used, for genes the
HGNC GeneSymbol annotation, respectively), the infor-
mation whether the respective gene/miRNA is upregu-
lated (’1’) or down-regulated (’−1’) has to be provided in
Laczny et al. BMC Bioinformatics 2012, 13:36
http://www.biomedcentral.com/1471-2105/13/36
Page 5 of 13the files by the user. Optionally, the disease of interest
can be specified to allow for convenient NCBI PubMed
queries for related information.
As the next step, the user can either choose a target-
prediction threshold for microCosm targets predictions
or can provide a list of custom pairwise miRNA - target
mRNA interactions, potentially originating from pro-
prietary experiments or other prediction algorithms.
The default threshold for microCosm targets predictions
is 0.01, amounting to around 280,000 miRNA - target
mRNA interactions. Here, the user can also opt-in for a
thorough GeneTrail analysis. Based on this information,
the analyses are then carried out and, finally, the user is
directed to the results. These will be stored uniquely for
each analysis performed and can be shared with others
by simply providing them with the link of the results
page. The results presented herein can be reproduced
using the example files provided by miRTrail.
The first provided analysis computes a contingency
table relating the dysregulation of miRNAs and the dys-
regulation of target mRNAs and calculates the according
p-value, based on a c
2 distribution. This analysis allows
for estimating whether there is an independance in the
deregulation of the miRNAs and the target mRNAs.
Second, a Venn diagram is computed, providing the
dysregulated genes that are targets of dysregulated miR-
NAs (overlap of the diagram), the not-dysregulated tar-
gets of dysregulated miRNAs (left part of the diagram)
and the dysregulated genes that are not targets of the
dysregulated miRNAs (right part of the diagram). For
this Venn diagram, a p-value using the Hypergeometric
distribution is calculated to show whether there exists a
significant overlap between dysregulated genes and tar-
gets of dysregulated miRNAs. Third, gene set enrich-
ment analyses for three gene sets are carried out using
the comprehensive functionality of GeneTrail. Indepen-
dently of each other, a so-called Over-Representation
Analysis (ORA) - based on the Hypergeometric distribu-
tion - is carried out for the dysregulated genes, targets
of dysregulated miRNAs and dysregulated targets of dys-
regulated miRNAs. In all cases, the gene sets are tested
for significant enrichments/depletions in KEGG path-
ways. If the user previously decided to perform all
GeneTrail analyses, the results will also include informa-
tion about GO terms, TransPath pathways, transcription
factors from Transfac, SNPs, and chromosomal location,
among many others. By clicking on the ‘details’ button,
the complete list of results is provided. Moreover, an
overview showing the biological categories being signifi-
cant in at least two of the three analyses is created. The
“code” represents in which of the pairwise overlaps the
respective category was found, similar to the file-permis-
sion scheme in Linux. So, a code of “2” e.g. shows that a
category was found in the enrichment analysis of the
dysregulated targets of dysregulated miRNAs as well as
in the results of the dysregulated genes. A code of “3”
would hence mean that this category was additionally
found in the results of the targets of dysregulated miR-
NAs. Accordingly in Table 2, e.g. the “DNA replication”
pathway was found to be enriched for dysregulated tar-
gets of dysregulated miRNAs as well as for the dysregu-
lated genes/mRNAs.
Finally, we carry out an integrative network-analysis
approach on the comprehensive network containing
dysregulated genes, dysregulated miRNAs, and the target
interactions between them. A subset of interesting miR-
NAs and their according targets is selected as well as a
custom degree constraint. The subset can be con-
structed either by selecting individual miRNAs, s. Figure
2, or miRNA families based on an Over-Representation
Analysis of miRNA-family data from miRBase (miFam.
d a t )[ 4 3 ] ,s .F i g u r e3 .T h ec u s t o md e g r e ec o n s t r a i n t
allows the selection of the genes being the target of at
l e a s ta sm a n ym i R N A sa ss p e c i f i e db yt h ep a r a m e t e r .
Based on this selection, using the Java Webstart-based
viewer BiNA [44] or the web-based viewer Cytoscape-
web [45], we show the resulting network, allowing for a
manual inspection of the inherent interactions. In the
network visualizations, nodes with rectangular shapes
belong to miRNAs, nodes with round shapes to genes,
red color means up-regulation, green color means
down-regulation, and genes and miRNAs are connected
by edges if a putative miRNA - target interaction exists.
Additionally, a more fine-grained ORA is available,
being performed only on the genes that are contained in
the custom selection, which is also separately available
as a list. These genes are assumed to be the most dis-
ease-relevant as they are found to be deregulated and
simultaneously putative targets of deregulated miRNAs
while, at the same time, being central to the network,
according to their degree. This list is analysed for
enrichments/depletions in KEGG pathways, Gene
Table 2 Overlapping pathways
Pathway Related mRNA set Code
Olfactory transduction 04740 a, b, c 7
DNA replication 03030 b, c 2
Lysosome 04142 b, c 2
Prostate cancer 05215 b, c 2
Small cell lung cancer 05222 b, c 2
Systemic lupus erythematosus 05322 b, c 2
a: Pathways related to targets of dereg. miRNAs
b: Pathways related to dereg. targets of dereg. miRNAs
c: Pathways related to dereg. mRNAs
Code: Arithmetic sum of the following:
1: Found for a and b
2: Found for b and c
4: Found for a and c
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human disease gene sets. A thorough GeneTrail analysis
can also be chosen here.
Melanoma case study
We compared the expression profiles of cutaneous
malignant melanoma to those of benign skin nevi sam-
ples from adult patients. While the proportion of mela-
noma cases among skin cancer patients is rather low
(4%), it accounts for almost 75% of all skin cancer-
related deaths. Even more, the prognosis for advanced
melanoma is very poor (5-year survival-rate is only 5%)
[46]. Hence, we decided to validate our tool based on
melanoma data and to identify new aspects of this dis-
ease, potentially helping in the creation of promising
new therapies for advanced melanoma patients.
An illustration of the the results page for the miRTrail
analysis on the melanoma miRNA and mRNA samples,
Figure 2 MiRNA selection (individual). Demonstrates the selection of miRNAs of interest. Link next to the each miRNA shows the respective
dysregulated target mRNAs.
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Figure 4.
Analysis of independance
Using our tool, for the melanoma samples and a predic-
tion threshold of 0.01 for the human miRNA - target
mRNA interactions from MicroCosm targets, we were
able to find statistical evidence about the dependance of
deregulation of miRNAs and target mRNAs. The contin-
gency table yielded a p-value of 0.025 (a = 0.05). Inter-
estingly, independant of the miRNA being up- or
downregulated, similar amounts of interactions were
found for targets, then, being up (450 and 480), down
Figure 3 MiRNA selection (families). Demonstrates the selection of miRNAs based on enriched miRNA families. All significant families (p(adj)
<0.05) are preselected.
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respectively. In turn, more targets were found to be up-
regulated for dysregulated miRNAs as well as for not
dysregulated miRNAs. Surprisingly, 805 (450 + 355)
interactions were found with both miRNA and predicted
target, being deregulated in the same direction. Finally,
as expected, a large number of interactions was found
were both, the miRNA and the predicted target, were
not deregulated (212782).
ORA of the three mRNA sets
Inspecting the ORA results, showed one KEGG path-
way (GPI-anchor biosynthesis) to be significantly
enriched for the set of targets of dysregulated miRNAs.
In turn, the over-representation analysis of dysregu-
lated targets of dysregulated miRNAs revealed nine
significant pathways, including cancer related cate-
gories, like Non-small cell lung cancer, Prostate cancer,
Small cell lung cancer, Endometrial cancer, and
Glioma as well as enrichments in the Lysosome path-
way and DNA replication. The analysis of the dysregu-
lated mRNAs revealed the highest number of
statistically signifi cant KEGG categories with a total of
24. Here again, several cancer-related pathways were
found to be enriched as well as pathways like Cell
cycle, Focal adhesion, or even signaling pathways (e.g.
TGF-beta signaling pathway).
Figure 4 Results Page. This illustrates the results page of a miRTrail analysis. The network visualization and subsequent analyses are available in
the subpanel at the bottom.
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pathway sets is described in Table 2. Among those, the
DNA replication pathway [47] as well as the Lysosome
pathway [48,49] have already been attributed to
melanoma.
Network analysis
From the 33 input miRNAs, 21 were found to have dysre-
gulated targets for a prediction threshold of 0.01. The
miRNA with the least dysregulated targets was hsa-miR-
211 (52 targets) while hsa-miR-23b was the miRNA with
the most dysregulated targets (115). For this analysis, we
decided to use the eight miRNAs having more than 80
dysregulated targets (miR-23b [50], miR-223, miR-193b
[51], miR-424, miR-20a [52], miR-98, miR-891a, and miR-
566), see Figure 2. We left the custom degree constraint at
the default of 1 for the subsequent ORA. The resulting
mRNA set comprises the dysregulated mRNAs that were
predicted targets of at least one of the eight earlier miR-
NAs. Specifying a higher constraint would lead to a smal-
ler network with only the mRNA nodes being targets of at
least as many miRNAs as specified by this parameter and
the according miRNA nodes, respectively.
ORA of subnetwork The analysis of KEGG pathways
showed significant enrichments for the three cancer-
related categories: Prostate cancer, Non-small cell lung
cancer, and Endometrial cancer. These categories were
found to be enriched for genes that were deregulated
while being targets of deregulated miRNAs, hence, the
genes that are assumed to be the most disease-relevant
due to their joint deregulation.
A total of 274 GO terms were found to be enriched or
depleted for all of the three GO-trees, with enrichments
in anti-apoptosis, cell proliferation, cell cycle, transcript
initiation, RNA elongation, and regulation of transla-
tional initiation among others in the biological subtree.
Furthermore, an enrichment (RASA1 and PTCH1) for
“Susceptibility to basal cell carcinoma” was found in the
OMIM categories.
Visualization For this step, we decided to focus on
smaller miRNA and mRNA sets to increase the visibility.
However, also large selections can be efficiently handled
and used for detailed manual inspections. Exemplary
visualization can be found in Figure 5 and 6, for BiNA
and for Cytoscape-web, respectively.
Conclusions
The constantly increasing availability of data from differ-
ent origins and of different nature allows for more com-
plex and comprehensive analyses. To this end, we
developed miRTrail to integrate information about RNA
deregulation in diseases and putative interactions of
miRNAs and mRNAs. Our tool provides a large
Figure 5 Visualization: BiNA. Subnetwork of top-8 miRNAs and a degree constraint for the target mRNAs of 3, thus, only seven miRNA nodes
are displayed. Round shape represents mRNAs, rectangular miRNAs, respectively. Red color indicates upregulation, green color downregulation,
respectively. Size of the mRNAs is according to their degree.
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Page 10 of 13collection of different analyses and performs in a trans-
parent way, requiring only minor activity by the user,
while offering versatile results. This greatly facilitates the
adaption of this tool as it does not require complicated
initial learning. Via the visualisation component, miR-
Trail enables the user to easily inspect the interactions
and, thus, also to further process upon the selection.
MiRTrail - results will also be of great help in any
scheme that aims in experimental confirmation of
miRNA-targets. The final proof, here, requires extended
experiments including the identification of the specific
targeted region of a gene by in vitro binding and the
analysis of in vivo effects by altered miRNA expression.
T h em e l a n o m ac a s es t u d ys h o w st h a tw ew e r ea b l et o
detect highly significant results, despite the fact that we
did not use autologous samples. This sets the ground
for specific experimental assays that focus on significant
miRNA - mRNA interactions in this tumor type. Hence,
miRTrail is of great interest for the life sciences commu-
nity as it can use data from next-generation sequencing,
qRT-PCR, or microarray experiments.
Availability and requirements
Project name: miRTrail
Project home page: http://mirtrail.bioinf.uni-sb.de
Operating system(s): Platform independent
Programming languages: C++, php
Other requirements: JavaWS version 1.6 or higher
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